Genetic associations of fatigue and other symptom domains of the acute sickness response to infection

Brain, Behavior, and Immunity

Volumn 26, Issue 4, 2012, Pages 552-558

  Piraino, B ^a   Vollmer Conna, U ^a   Lloyd, A R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Acute sickness response; Cytokine; Fatigue; Genetic association; Polymorphisms

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; ALLELE; ARTICLE; COGNITIVE DEFECT; FATIGUE; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PAIN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM;

ADULT; ALPHAVIRUS INFECTIONS; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; FATIGUE; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INFECTION; MALE; PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; Q FEVER; ROSS RIVER VIRUS; SEVERITY OF ILLNESS INDEX;

EID: 84859431988     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.12.009     Document Type: Article

References (44)

1. Arvin, A. M., 2001. Varicella-zoster virus. Fields Virology. D. M. Knipe and P. M. Howley. Lippincott-Raven, Philadelphia. 2, 2731-2768.
2. Barsky A.J., Peekna H.M., Borus J.F. Somatic symptom reporting in women and men. J. Gen. Intern. Med. 2001, 16:266-275.
3. Bob P., Raboch J., Maes M., Susta M., Pavlat J., Jasova D., Vevera J., Uhrova J., Benakova H., Zima T. Depression, traumatic stress and interleukin-6. J. Affect. Disord. 2010, 120:231-234.
4. Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A., Walmsley S.L., Mazzulli T., Avendano M., Derkach P., Ephtimios I.E., Kitai I., Mederski B.D., Shadowitz S.B., Gold W.L., Hawryluck L.A., Rea E., Chenkin J.S., Cescon D.W., Poutanen S.M., Detsky A.S. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003, 289:2801-2809.
5. Cannon T.D., Keller M.C. Endophenotypes in the genetic analyses of mental disorders. Annu. Rev. Clin. Psychol. 2006, 2:267-290.
6. Cannon T.D., Gasperoni T.L., van Erp T.G., Rosso I.M. Quantitative neural indicators of liability to schizophrenia: implications for molecular genetic studies. Am. J. Med. Genet. 2001, 105:16-19.
7. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 2004, 500:399-411.
8. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
9. Fan C.K., Yieh K.M., Peng M.Y., Lin J.C., Wang N.C., Chang F.Y. Clinical and laboratory features in the early stage of severe acute respiratory syndrome. J. Microbiol. Immunol. Infect. 2006, 39:45-53.
10. Gallin J.I., Malech H.L., Weening R.S., et al. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N. Engl. J. Med. 1991, 324:509-516.
11. Gijsbers van Wijk C.M., van Vliet K.P., Kolk A.M., Everaerd W.T. Symptom sensitivity and sex differences in physical morbidity: a review of health surveys in the United States and The Netherlands. Women Health 1991, 17:91-124.
12. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
13. Hadzi-Pavlovic D., Hickie I.B., Wilson A.J., Davenport T.A., Lloyd A.R., Wakefield D. Screening for prolonged fatigue syndromes: validation of the SOFA scale. Soc. Psychiatry Psychiatr. Epidemiol. 2000, 35:471-479.
14. Harley D., Sleigh A., Ritchie S. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin. Microbiol. Rev. 2001, 14:909-932. table of contents.
15. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
16. Hickie I., Davenport T.A., Hadzi-Pavlovic D., Koschera A., Naismith S.L., Scott E.M., Wilhelm K.A. Development of a simple screening tool for common mental disorders in general practice. Med. J. Aust. 2001, 175:S10-S17.
17. Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S.D., Reeves W.C., Lloyd A. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006, 333:575-580.
18. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002, 25:154-159.
19. Kroenke K., Spitzer R.L. Gender differences in the reporting of physical and somatoform symptoms. Psychosom. Med. 1998, 60:150-155.
20. Krzyszton C.P., Sparkman N.L., Grant R.W., Buchanan J.B., Broussard S.R., Woods J., Johnson R.W. Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1109-R1114.
21. Kubera M., Kenis G., Bosmans E., Zieba A., Dudek D., Nowak G., Maes M. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol. J. Pharmacol. 2000, 52:237-241.
22. Kung W.J., Lin C.C., Liu S.H., Chaung H.C. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technol. Ther. 2010, 12:809-813.
23. Leone M., Honstettre A., Lepidi H., Capo C., Bayard F., Raoult D., Mege J.L. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol. J. Infect. Dis. 2004, 189:339-345.
24. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997, 9:853-858.
25. Mandell, Douglas, and Bennett;s principles and practice of infectious diseases 2005, Elsevier, Churchill Livingstone, New York. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
26. Marrie T.J. Q fever 2000, CRC Press, Inc., Florida.
27. Maurin M., Raoult D. Q fever. Clin. Microbiol. Rev. 1999, 12:518-553.
28. Mesquita A.R., Correia-Neves M., Roque S., Castro A.G., Vieira P., Pedrosa J., Palha J.A., Sousa N. IL-10 modulates depressive-like behavior. J. Psychiatr. Res. 2008, 43:89-97.
29. Muller M.P., Richardson S.E., McGeer A., Dresser L., Raboud J., Mazzulli T., Loeb M., Louie M. Early diagnosis of SARS: lessons from the Toronto SARS outbreak. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:230-237.
30. Mylonas A., Brown A., Carthew T., McGrath B., Purdie D., Pandeya N., Vecchio P., Collins L., Gardner I., de Looze F., Reymond E., Suhrbier A. Natural history of Ross River virus-induced epidemic polyarthritis. Med. J. Aust. 2002, 177:356-360.
31. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., Hutchinson I.V. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur. J. Immunogenet. 1999, 26:1-3.
32. Pravica V., Perrey C., Stevens A., Lee J.H., Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol. 2000, 61:863-866.
33. Raghu G., Brown K.K., Bradford W.Z., Starko K., Noble P.W., Schwartz D.A., King T.E. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2004, 350:125-133.
34. Ruan Y.J., Wei C.L., Ee A.L., Vega V.B., Thoreau H., Su S.T., Chia J.M., Ng P., Chiu K.P., Lim L., Zhang T., Peng C.K., Lin E.O., Lee N.M., Yee S.L., Ng L.F., Chee R.E., Stanton L.W., Long P.M., Liu E.T. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003, 361:1779-1785.
35. Salemi M., Fitch W.M., Ciccozzi M., Ruiz-Alvarez M.J., Rezza G., Lewis M.J. Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis. J. Virol. 2004, 78:1602-1603.
36. Tissot Dupont H., Raoult D., Brouqui P., Janbon F., Peyramond D., Weiller P.J., Chicheportiche C., Nezri M., Poirier R. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am. J. Med. 1992, 93:427-434.
37. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 1997, 24:1-8.
38. Vetsika E.K., Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev. Mol. Med. 2004, 6:1-16.
39. Vollmer-Conna U. Acute sickness behaviour: an immune system-to-brain communication?. Psychol. Med. 2001, 31:761-767.
40. Vollmer-Conna U., Fazou C., Cameron B., Li H., Brennan C., Luck L., Davenport T., Wakefield D., Hickie I., Lloyd A. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol. Med. 2004, 34:1289-1297.
41. Vollmer-Conna U., Piraino B.F., Cameron B., Davenport T., Hickie I., Wakefield D., Lloyd A.R. Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin. Infect. Dis. 2008, 47:1418-1425.
42. Von Korff M., Ustun T.B., Ormel J., Kaplan I., Simon G.E. Self-report disability in an international primary care study of psychological illness. J. Clin. Epidemiol. 1996, 49:297-303.
43. Wang J.T., Sheng W.H., Fang C.T., Chen Y.C., Wang J.L., Yu C.J., Chang S.C., Yang P.C. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg. Infect. Dis. 2004, 10:818-824.
44. Zouk H., McGirr A., Lebel V., Benkelfat C., Rouleau G., Turecki G. The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B:996-1002.